Prelude Therapeutics Incorporated (PRLD) financial statements (2022 and earlier)

Company profile

Business Address 200 POWDER MILL ROAD
WILMINGTON, DE 19803
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments291,233218,309
Cash and cash equivalents31,828218,309
Short-term investments259,405 
Deferred costs 300
Other undisclosed current assets3,8822,200
Total current assets:295,115220,809
Noncurrent Assets
Operating lease, right-of-use asset1,707 
Property, plant and equipment3,9292,480
Other undisclosed noncurrent assets4,347301
Total noncurrent assets:9,9832,781
TOTAL ASSETS:305,098223,590
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities17,46111,375
Accounts payable7,8403,920
Accrued liabilities9,6217,455
Other undisclosed current liabilities1,740 
Total current liabilities:19,20111,375
Noncurrent Liabilities
Liabilities, other than long-term debt 32
Other liabilities 32
Total noncurrent liabilities: 32
Total liabilities:19,20111,407
Stockholders' equity
Stockholders' equity attributable to parent, including:285,897212,183
Additional paid in capital505,723319,605
Accumulated other comprehensive loss(711) 
Accumulated deficit(219,120)(107,426)
Other undisclosed stockholders' equity attributable to parent54
Total stockholders' equity:285,897212,183
TOTAL LIABILITIES AND EQUITY:305,098223,590

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Operating expenses(113,735)(58,763)
Operating loss:(113,735)(58,763)
Nonoperating income
(Other Nonoperating income)
2,0411,834
Net loss available to common stockholders, diluted:(111,694)(56,929)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net loss:(111,694)(56,929)
Comprehensive loss:(111,694)(56,929)
Other undisclosed comprehensive loss, net of tax, attributable to parent(711) 
Comprehensive loss, net of tax, attributable to parent:(112,405)(56,929)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: